# LEU — AI stock forecast & analysis

> AI-generated analysis by K3vl4r — 2026-08-06. Informational only, not financial advice.

**Recommendation:** HOLD

**Scores (0–100):** Overall 5.6 · Fundamentals 5.4 · Technicals 5.8 · Growth 8.2 · Risk 7.8

## Summary

Centrus retains a genuine structural moat as the sole U.S.-licensed HALEU enricher with a fresh $1B+ DOE contract, $1.87B cash, and a $3.9B+ backlog, but Q2'26 print (Aug 5 AMC) missed EPS while beating revenue, sending shares ~5.7% lower after-hours. At ~$187 with forward P/E ~68x, EV/EBITDA ~73x, negative TTM operating margin, and Q1'26 FCF burn of -$58M, valuation offers no cushion — the stock is caught between a legitimate long-term monopoly narrative and near-term margin/dilution overhang.

## Price targets (6-month horizon)

- Bear: $145.00
- Base: $178.00
- Bull: $215.00

## News context

The signal news is the July 1 finalization of a $1B+ DOE HALEU contract (including options) plus early delivery of 900kg HALEU UF6 under the prior demo contract — this is real, materially de-risks the enrichment expansion narrative, and validates the sole-U.S.-licensee moat. Layer in the new Oklo partnership and the $560M Oak Ridge expansion and the multi-year growth story is credible. Against that, the Q2'26 print last night was mixed: revenue $176.1M beat (+14% YoY) but GAAP EPS $0.77 missed, sending shares -5.7% after hours. JP Morgan cut its target to $178 from $236 on July 29 and estimate revisions ahead of the print were negative — the sell-side had already been trimming expectations. Institutional ownership rose meaningfully (+6.8pp to ~78-79%) which is a positive positioning shift, but short float also climbed to 26.4% (+3.3pp) — informed hedged/short positioning is building into the multi-year capex ramp.

## About
- Methodology: https://app.k3vl4r.com/methodology
- Full report: https://app.k3vl4r.com/r/leu-ai-stock-forecast-2c7164301c11b8eef14245d1b2377501
- AI-generated; model outputs can be wrong. Not financial advice.